These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 12140283)

  • 1. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.
    Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H
    J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of biglycan gene expression by transforming growth factor-beta requires MKK6-p38 mitogen-activated protein Kinase signaling downstream of Smad signaling.
    Ungefroren H; Lenschow W; Chen WB; Faendrich F; Kalthoff H
    J Biol Chem; 2003 Mar; 278(13):11041-9. PubMed ID: 12538652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
    Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
    Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta.
    Ungefroren H; Groth S; Ruhnke M; Kalthoff H; Fändrich F
    J Biol Chem; 2005 Jan; 280(4):2644-52. PubMed ID: 15546867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta. Evidence for oxidative signaling through NADPH oxidase.
    Groth S; Schulze M; Kalthoff H; Fändrich F; Ungefroren H
    J Biol Chem; 2005 Sep; 280(39):33190-9. PubMed ID: 16051607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.
    Grau AM; Zhang L; Wang W; Ruan S; Evans DB; Abbruzzese JL; Zhang W; Chiao PJ
    Cancer Res; 1997 Sep; 57(18):3929-34. PubMed ID: 9307274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
    Yuan W; Varga J
    J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells.
    Watanabe H; de Caestecker MP; Yamada Y
    J Biol Chem; 2001 Apr; 276(17):14466-73. PubMed ID: 11278290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
    Kleeff J; Ishiwata T; Maruyama H; Friess H; Truong P; Büchler MW; Falb D; Korc M
    Oncogene; 1999 Sep; 18(39):5363-72. PubMed ID: 10498890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
    Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
    Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells.
    Calonge MJ; Massagué J
    J Biol Chem; 1999 Nov; 274(47):33637-43. PubMed ID: 10559252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD.
    Wang H; Yang GH; Bu H; Zhou Q; Guo LX; Wang SL; Ye L
    Int J Exp Pathol; 2003 Jun; 84(3):153-63. PubMed ID: 12974945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smads in human trophoblast cells: expression, regulation and role in TGF-beta-induced transcriptional activity.
    Wu D; Luo S; Wang Y; Zhuang L; Chen Y; Peng C
    Mol Cell Endocrinol; 2001 Apr; 175(1-2):111-21. PubMed ID: 11325521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
    He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
    Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle.
    Chiao PJ; Hunt KK; Grau AM; Abramian A; Fleming J; Zhang W; Breslin T; Abbruzzese JL; Evans DB
    Ann N Y Acad Sci; 1999 Jun; 880():31-7. PubMed ID: 10415848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.
    Poncelet AC; Schnaper HW
    J Biol Chem; 2001 Mar; 276(10):6983-92. PubMed ID: 11114293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and expression of betaig-h3 in pancreatic cancer cells.
    Schneider D; Kleeff J; Berberat PO; Zhu Z; Korc M; Friess H; Büchler MW
    Biochim Biophys Acta; 2002 Oct; 1588(1):1-6. PubMed ID: 12379307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.